tradingkey.logo

Fortrea Holdings Inc

FTRE
View Detailed Chart

6.500USD

+1.040+19.05%
Market hours ETQuotes delayed by 15 min
588.28MMarket Cap
LossP/E TTM

Fortrea Holdings Inc

6.500

+1.040+19.05%
Intraday
1m
30m
1h
D
W
M
D

Today

+19.05%

5 Days

-4.41%

1 Month

+24.53%

6 Months

-58.52%

Year to Date

-65.15%

1 Year

-75.45%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 11 analysts
HOLD
Current Rating
5.875
Target Price
7.60%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Fortrea Holdings Inc
FTRE
11
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(2)
Buy(6)
Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.050
Buy
RSI(14)
48.212
Neutral
STOCH(KDJ)(9,3,3)
45.671
Sell
ATR(14)
0.552
High Vlolatility
CCI(14)
-11.801
Neutral
Williams %R
58.896
Sell
TRIX(12,20)
0.931
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
6.126
Buy
MA10
6.071
Buy
MA20
5.482
Buy
MA50
5.204
Buy
MA100
5.948
Buy
MA200
11.913
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Ticker SymbolFTRE
CompanyFortrea Holdings Inc
CEOMr. Anshul Thakrala
Websitehttps://www.fortrea.com/
KeyAI